Guides › Introduction to combination therapy

New options in 2010/11

Treatment options for first treatment are unlikely to change much over the next year.

The most recently approved drugs include a integrase inhibitor (raltegravir) and a CCR5 inhibitor (maraviroc). However they are rarely used in first-line treatment.

Raltegravir with two nukes is approved for first-line treatment but tends to be saved for second-line treatment. Maraviroc is not approved for first-line treatment in Europe.

As these drugs are more expensive than current recommended treatment, this also limits their use.

A detailed overview of new antiretrovirals for adults and children is posted to the i-Base website. See page 44 for further information and a link.

July 2010

Decisions relating to your treatment should always be taken in consultation with your doctor. Information in this guide is intended to support those discussions.

Authors and references • Translations • About our guides • Guides index

This guide's available in UK clinics (can't find it?)

We comply with the HONcode standard for trustworthy health information: verify here